| 上海医药财务报表 |
评论“上海医药” |
|
|
|
|
| 项目 |
2001年 |
2000年 |
1999年 |
| 一、主营业务收入 |
5,202,034,176.00 |
4,607,774,720.00 |
4,537,195,008.00 |
| 减：折扣与折让 |
0.00 |
12,521,166.00 |
7,262,356.50 |
| 主营业务收入净额 |
5,202,034,176.00 |
4,595,253,760.00 |
4,529,932,288.00 |
| 减：主营业务成本 |
4,491,684,352.00 |
4,003,788,032.00 |
3,970,004,736.00 |
| 主营业务税金及附加 |
12,964,499.00 |
9,133,624.00 |
6,301,207.00 |
| 二、主营业务利润 |
697,385,280.00 |
582,332,032.00 |
553,626,560.00 |
| 加：其它业务利润 |
8,558,850.00 |
5,470,098.00 |
9,195,353.00 |
| 减：存货跌价损失 |
0.00 |
-4,922,559.00 |
8,118,872.00 |
| 营业费用 |
199,865,600.00 |
166,616,240.00 |
156,347,584.00 |
| 管理费用 |
331,479,936.00 |
237,394,896.00 |
216,659,824.00 |
| 财务费用 |
6,243,258.00 |
39,579,908.00 |
48,319,276.00 |
| 销售费用 |
|
149,133,664.00 |
|
| 三、营业利润 |
168,355,344.00 |
69,312,000.00 |
133,376,368.00 |
| 加：投资收益 |
34,985,700.00 |
|
4,133,355.25 |
| 补贴收入 |
4,421,461.50 |
4,871,707.00 |
2,868,753.00 |
| 营业外收入 |
591,131.69 |
2,889,798.75 |
3,722,621.75 |
| 减：营业外支出 |
6,013,585.00 |
3,927,921.25 |
6,161,123.00 |
| 四、利润总额 |
202,340,048.00 |
222,279,248.00 |
137,939,968.00 |
| 减：所得税 |
27,570,498.00 |
17,624,966.00 |
27,102,866.00 |
| 减：少数股东损益 |
29,488,808.00 |
19,816,826.00 |
|
| 加：财政返还（含所得税返还） |
|
|
|
| 五、净利润 |
145,280,752.00 |
184,837,456.00 |
94,425,544.00 |
| 加：年初未分配利润 |
90,620,928.00 |
|
28,848,768.00 |
| 盈余公积金转入 |
0.00 |
|
|
| 六、可供分配的利润 |
235,901,680.00 |
217,314,432.00 |
123,274,312.00 |
| 减：提取法定公积金 |
25,856,486.00 |
32,606,544.00 |
11,056,703.00 |
| 提取法定公益金 |
25,225,422.00 |
32,243,716.00 |
10,874,938.00 |
| 七、可供股东分配的利润 |
184,460,768.00 |
238,684.77 |
101,342,672.00 |
| 减：应付优先股股利 |
0.00 |
152,225,488.00 |
|
| 提取任意盈余公积 |
|
5,960,533.50 |
|
| 提取任意公积 |
1,101,873.25 |
|
|
| 应付普通股股利 |
28,458,644.00 |
22,955,230.00 |
22,955,230.00 |
| 转做股本的普通股股利 |
0.00 |
|
45,910,460.00 |
|
